Literature DB >> 1965955

Plasminogen receptors in the mediation of pericellular proteolysis.

E F Plow1, L A Miles.   

Abstract

A wide variety of cells bind plasminogen with very high capacity, with similar affinity and recognize the same structural features within the plasminogen molecule. As a consequence of binding to cell surfaces, plasminogen is more readily activated to plasmin. Plasmin remains cell-bound where it can degrade matrix constituents and is protected from inactivation by alpha 2-antiplasmin. Thus, the functional consequence of plasminogen binding to cells is pericellular proteolysis, permitting cell migration. Both proteins and nonprotein cell-surface constituents function as plasminogen binding sites. Gangliosides exhibit the appropriate properties of the non-protein plasminogen receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1965955     DOI: 10.1016/0922-3371(90)90042-u

Source DB:  PubMed          Journal:  Cell Differ Dev        ISSN: 0922-3371


  13 in total

Review 1.  The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer.

Authors:  G Cox; W P Steward; K J O'Byrne
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

Review 2.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.

Authors:  Toni M Antalis; Marguerite S Buzza; Kathryn M Hodge; John D Hooper; Sarah Netzel-Arnett
Journal:  Biochem J       Date:  2010-06-15       Impact factor: 3.857

Review 3.  The plasminogen activator/plasmin system.

Authors:  J D Vassalli; A P Sappino; D Belin
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

4.  PEGylated DX-1000: pharmacokinetics and antineoplastic activity of a specific plasmin inhibitor.

Authors:  Laetitia Devy; Shafaat A Rabbani; Mark Stochl; Mary Ruskowski; Ian Mackie; Laurent Naa; Mark Toews; Reinoud van Gool; Jie Chen; Art Ley; Robert C Ladner; Daniel T Dransfield; Paula Henderikx
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

5.  Purification and characterization of two forms of a high-molecular-weight cysteine proteinase (porphypain) from Porphyromonas gingivalis.

Authors:  P Ciborowski; M Nishikata; R D Allen; M S Lantz
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

6.  Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation.

Authors:  Nicholas M Andronicos; Emily I Chen; Nagyung Baik; Hongdong Bai; Caitlin M Parmer; William B Kiosses; Mark P Kamps; John R Yates; Robert J Parmer; Lindsey A Miles
Journal:  Blood       Date:  2009-11-06       Impact factor: 22.113

7.  Endotoxin stimulates expression of the murine urokinase receptor gene in vivo.

Authors:  F Almus-Jacobs; N Varki; M S Sawdey; D J Loskutoff
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

Review 8.  Mechanisms of disease: protease functions in intestinal mucosal pathobiology.

Authors:  Toni M Antalis; Terez Shea-Donohue; Stefanie N Vogel; Cynthia Sears; Alessio Fasano
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2007-07

9.  Increased plasminogen binding is associated with metastatic breast cancer cells: differential expression of plasminogen binding proteins.

Authors:  M Ranson; N M Andronicos; M J O'Mullane; M S Baker
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

10.  Characterization of plasminogen binding to NB4 promyelocytic cells using monoclonal antibodies against receptor-induced binding sites in cell-bound plasminogen.

Authors:  Mercè Jardí; Pere Fàbregas; María Sagarra-Tió; María José Pérez-Lucena; Jordi Félez
Journal:  J Biomed Biotechnol       Date:  2012-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.